e detection and analysis of cell-free dna in patients ’ blood are becoming increasingly accepted in oncology . newline_char in patients with resectable colorectal cancers , higher amounts of preoperative circulating tumor dna were associated with disease recurrence and decreased overall survival . story_separator_special_tag the test detected stage 1 or 2 colon , breast , lung or ovarian cancers between 59 percent and 71 percent of the time when assessing 200 patients previously diagnosed with cancer , researchers found . newline_char by reviewing these dna fragments for mutations found in 58 " cancer-driver " genes , the blood test detects many early stage cancers without rendering false positives for healthy people , said velculescu , co-director of cancer biology at the johns hopkins kimmel cancer center , in baltimore . newline_char " to develop a genetic blood test for cancer , researchers must find ways to spot dna mutations linked to cancer while ignoring natural and harmless mutations that regularly occur in humans , velculescu explained  newline_char 16 , 2017 ( healthday news ) -- a new genetic blood test might pave the way for detecting early stage cancers that often prove fatal when caught too late , a new study suggests . newline_char the test scans blood for dna fragments released by cancerous tumors , explained lead researcher dr. story_separator_special_tag ” several companies already offer tests that can detect cancer dna in the blood of patients with late-stage cancers . newline_char chicago ( reuters ) - a test that scans blood for tumor-specific dna identified early-stage cancer in more than half of 138 patients with the disease , u.s. researchers reported on wednesday , marking a new milestone in the rush for so-called “ liquid biopsies. newline_char researchers behind the early-stage test hope it could be used to identify cancers at a stage when patients have a better chance at survival .
